DT
HealthMore in Health→
Weight Loss Drug Tied to Lower Eye Disease Risk in Diabetics
Large-scale study finds GLP-1 receptor agonists significantly reduce diabetic retinopathy risk and other eye complications in type 2 diabetes patients.
Key Takeaways
- A large-scale study finds GLP-1 receptor agonist users have significantly lower risk of diabetic retinopathy and eye complications
- The findings add eye health to a growing list of benefits including cardiovascular and renal protection from these drugs
DE
DT Editorial Team··5 min read·via medicalxpress.com